

Fundamental dimension Equity attribute | CRUSLeader $112.32▲+1.66% Cap $5.63BP/E 13.3x QuantScore68/100 | ADIPeer $391.07▲+1.38% Cap $189.5BP/E 46.2x QuantScore67/100 | ALGMPeer $31.48▼-0.66% Cap $5.87BP/E 388.6x QuantScore52/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
56/100 |
68/100 |
25/100 |
Valuation Multiples, PEG & DCF upside | 99/100 | 42/100 | 20/100 |
Health Piotroski, Altman Z, leverage & liquidity | 100/100 | 77/100 | 75/100 |
Growth Revenue / earnings growth & margins | 31/100 | 64/100 | 59/100 |
Sentiment Analyst ratings, targets & revisions | 52/100 | 85/100 | 83/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 13.3x | 46.2x | 388.6x |
Forward P/E (next FY) | 13.3x | 30.4x | 30.6x |
EV / EBITDA (TTM) | 9.0x | 28.0x | 57.7x |
Price / Sales | 2.7x | 13.7x | 6.2x |
Price / Free Cash Flow | 9.8x | 38.4x | 66.4x |
PEG ratio | 0.48 | 0.40 | 0.72 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 8 / 9 | 8 / 9 | 7 / 9 |
Altman Z-Score | 11.27 (Safe) | 8.67 (Safe) | 8.91 (Safe) |
Total debt / equity | 0.08 | 0.27 | 0.30 |
Quick ratio | 6.2x | 0.9x | 2.3x |
Interest coverage | 471.0x | 14.1x | 2.2x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +5.3% | +16.9% | +22.8% |
Net income growth YoY | +25.0% | +38.7% | +79.6% |
Gross margin (TTM) | 52.8% | 65.8% | 47.2% |
Operating margin (FY) | 23.0% | 26.6% | 4.8% |
FCF margin (FY) | 31.9% | 38.8% | 14.0% |
5. Trailing price performancePrice change over period |
1M return | -5.5% | +2.2% | -10.4% |
3M return | -15.9% | +5.2% | -31.6% |
6M return | -35.5% | -2.1% | -28.7% |
Year to date | -5.2% | +44.2% | +19.3% |
1Y return | -14.0% | +64.3% | +1.8% |
3Y return | +67.4% | +137.1% | +9.4% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $156.92 +39.7% upside | $172.35 -55.9% premium | $3.39 -89.2% premium |
Wall Street consensus target | $160.00 +42.5% · range $130.00–$190.00 | $480.24 +22.8% · range $405.00–$675.00 | $54.00 +71.5% · range $45.00–$67.00 |
Consensus stance | 64% Buy23% Hold14% Sell | 83% Buy17% Hold-0% Sell | 92% Buy8% Hold0% Sell |